Martine Rothblatt

2010

In 2010, Martine Rothblatt earned a total compensation of $17.6M as Chief Executive Officer at United Therapeutics, which was about the same as previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,526,156
Non-Equity Incentive Plan$900,000
Option Awards$14,263,681
Salary$874,768
Other$56,203
Total$17,620,808

Rothblatt received $14.3M in option awards, accounting for 81% of the total pay in 2010.

Rothblatt also received $1.5M of change in pension value and nonqualified deferred compensation earnings, $900K in non-equity incentive plan, $874.8K in salary and $56.2K in other compensation.

Rankings

In 2010, Martine Rothblatt's compensation ranked 105th out of 10,439 executives tracked by ExecPay. In other words, Rothblatt earned more than 99.0% of executives.

ClassificationRankingPercentile
All
105
out of 10,439
99th
Division
Manufacturing
36
out of 3,838
99th
Major group
Chemicals And Allied Products
6
out of 926
99th
Industry group
Drugs
5
out of 685
99th
Industry
Pharmaceutical Preparations
4
out of 481
99th
Source: SEC filing on April 30, 2012.

Rothblatt's colleagues

We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2010.

2010

Roger Jeffs

United Therapeutics

Chief Operating Officer

2010

Paul Mahon

United Therapeutics

General Counsel

2010

John Ferrari

United Therapeutics

Chief Financial Officer

News

In-depth

You may also like